Phio Pharmaceuticals Corp. (PHIO)

NASDAQ: PHIO · Real-Time Price · USD

0.7710

-0.0408 (-5.03%)

At close: Nov 13, 2026, 4:00 PM EST

0.8100

+0.0390 (5.06%)

After-hours: Nov 13, 2026, 7:05 PM EST

Phio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.61	21.03	5.38	8.49	11.78	24.06
Cash & Short-Term Investments	10.61	21.03	5.38	8.49	11.78	24.06
Cash Growth	-0.90%	290.77%	-36.61%	-27.93%	-51.03%	68.89%
Prepaid Expenses	0.7	0.45	0.35	0.83	0.62	0.62
Restricted Cash	-	-	-	-	0.05	0.05
Total Current Assets	11.31	21.48	5.74	9.32	12.45	24.73
Property, Plant & Equipment	0.01	0.01	0	0.04	0.34	0.42
Other Long-Term Assets	-	-	-	0	0.02	0.03
Total Assets	11.32	21.49	5.74	9.36	12.81	25.17

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.89	0.44	0.25	0.66	0.78	0.28
Accrued Expenses	1.81	0.91	0.76	0.94	1.01	2.66
Current Portion of Leases	-	-	-	0.04	0.14	0.13
Other Current Liabilities	-	-	-	-	0.02	-
Total Current Liabilities	2.7	1.34	1.02	1.63	1.94	3.07
Long-Term Leases	-	-	-	-	0.04	0.17
Total Liabilities	2.7	1.34	1.02	1.63	1.97	3.24

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	-	-	-	-
Additional Paid-In Capital	175.97	175.2	151.08	146.94	139.22	138.83
Retained Earnings	-167.36	-155.05	-146.36	-139.21	-128.38	-116.9
Total Common Equity	8.62	20.15	4.72	7.73	10.84	21.93
Shareholders' Equity	8.62	20.15	4.72	7.73	10.84	21.93
Total Liabilities & Equity	11.32	21.49	5.74	9.36	12.81	25.17

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	0.04	0.17	0.3
Net Cash (Debt)	10.61	21.03	5.38	8.46	11.61	23.76
Net Cash Growth	-0.90%	290.77%	-36.34%	-27.18%	-51.14%	74.69%
Net Cash Per Share	0.96	3.51	6.83	36.52	91.94	200.01
Filing Date Shares Outstanding	11.95	11.62	4.78	0.51	0.13	0.13
Total Common Shares Outstanding	11.95	11.62	1.73	0.42	0.13	0.13
Working Capital	8.61	20.14	4.72	7.69	10.51	21.66
Book Value Per Share	0.72	1.73	2.72	18.57	85.64	175.00
Tangible Book Value	8.62	20.15	4.72	7.73	10.84	21.93
Tangible Book Value Per Share	0.72	1.73	2.72	18.57	85.64	175.00
Machinery	-	0.24	0.31	1.1	1.31	1.19
Leasehold Improvements	-	-	-	0.05	0.05	0.05

SEC Filings: 10-K · 10-Q